1. Home
  2. IH vs MXCT Comparison

IH vs MXCT Comparison

Compare IH & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.68

Market Cap

82.8M

Sector

Real Estate

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$0.81

Market Cap

93.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
MXCT
Founded
1996
1999
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.8M
93.0M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
IH
MXCT
Price
$1.68
$0.81
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
8.4K
559.4K
Earning Date
03-31-2026
05-12-2026
Dividend Yield
5.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.50
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$0.64
52 Week High
$3.60
$2.40

Technical Indicators

Market Signals
Indicator
IH
MXCT
Relative Strength Index (RSI) 44.86 46.61
Support Level $1.55 $0.77
Resistance Level $1.83 $0.89
Average True Range (ATR) 0.08 0.05
MACD -0.00 -0.01
Stochastic Oscillator 21.43 21.75

Price Performance

Historical Comparison
IH
MXCT

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: